Manager, Clinical Finance Business Partner
SystImmune Inc. is a clinical-stage biopharmaceutical company located in Redmond, WA. It specializes in developing innovative cancer treatments using its established drug development platforms, focusing on bi-specific, multi-specific antibodies, and antibody-drug conjugates (ADCs). SystImmune has several assets in various stages of clinical trials for solid tumor and hematologic indications. Alongside ongoing clinical trials, SystImmune has a strong preclinical pipeline of potential cancer therapeutics in the discovery or IND-enabling stages, representing cutting-edge biologics development.
Position Summary:
The Manager, Clinical Finance Business Partner will lead the financial planning and analysis efforts for the clinical portfolio of the company. This strategic role is responsible for developing and overseeing financial models, budgets, and forecasts that support our clinical development objectives. This role will also be responsible for managing finance-related issues with external alliance partners. The Clinical Finance Business Partner will collaborate with cross-functional teams to ensure financial alignment with clinical timelines and corporate goals, ultimately driving informed decision-making and resource allocation.
Key Responsibilities:
Manage the financial aspects of a clinical development project, including budgeting, forecasting, and tracking actuals for multiple indications and clinical trials.
Serve as a key member of the Clinical Project Team, translating project milestones and activities into comprehensive financial metrics and providing decision-making support.
Ensure transparency and visibility of project budgets to all relevant stakeholders, identifying and communicating financial risks and opportunities.
Analyze financial variances as the project progresses and identify areas of financial R/O (Risks and Opportunities).
Prepare financial reports for senior management, outlining the financial implications of investment decisions, and ensure alignment with company-wide strategic initiatives and business goals.
Collaborate with CMO team to integrate all relevant financial components into the global project view and ensure compliance with financial procedures.
Provide budgeting and reporting on externally partnered projects in collaboration with Business Development and Alliance Management teams, ensuring accurate representation of financial data and commitments
Develop key performance indicators (KPIs) to track the financial health of clinical operations and identify areas for improvement.
Negotiate and manage contracts with vendors, third-party providers, and insurance companies, ensuring favorable financial terms.
Required Qualifications:
Bachelor’s degree in Finance, Accounting, or a related field.
Manager: 3+ years of experience in financial planning and analysis.
Experience in a clinical stage pharmaceutical or biotech company with a strong understanding of clinical trial design and cost drivers, including FTE costs, external clinical costs, and non-clinical expenses.
Proficiency in financial analysis, budgeting, and forecasting techniques.
Strong proficiency in financial modeling and data analysis tools (Excel, financial software).
Strong communication skills with the ability to present complex financial concepts to non-financial stakeholders.
Strong analytical skills and attention to detail, with a proactive approach to problem-solving.
Preferred Qualifications:
Equivalent of MBA, CPA or advanced degree in Finance, Accounting
Familiarity with regulatory requirements and compliance standards in the biotech industry.
Demonstrated success in managing projects in a fast-paced, dynamic environment.
Ability to cultivate relationships across departments to enhance financial integration within the organization.
The hiring pay range for this position is $90,000 - $140,000 per year based on skills, education, and experience relevant to the role.
SystImmune is a leading and well-funded clinical-stage biopharmaceutical company located in Redmond, WA and Princeton, NJ. It specializes in developing innovative cancer treatments using its established drug development platforms, focusing on bi-specific, multi-specific antibodies, and antibody-drug conjugates (ADCs). SystImmune has multiple assets in various stages of clinical trials for solid tumor and hematologic indications. Alongside ongoing clinical trials, SystImmune has a robust preclinical pipeline of potential cancer therapeutics in the discovery or IND-enabling stages, representing cutting-edge biologics development. We offer an opportunity for you to learn and grow while making significant contributions to the company’s success. SystImmune offers a comprehensive benefits package.
SystImmune is an Equal Opportunity Employer. We welcome diverse talent and encourage all qualified applicants to apply.